Sandu Pharmaceuticals Limited (BOM:524703)

Market Cap	322.29M -37.8%
Revenue (ttm)	671.50M -2.3%
Net Income	20.52M +13.0%
EPS	2.11 +12.2%
Shares Out	9.66M
PE Ratio	15.82
Forward PE	n/a
Dividend	0.80 (2.35%)
Ex-Dividend Date	Sep 18, 2025

Volume	3,340
Average Volume	3,681
Open	38.70
Previous Close	34.00
Day's Range	33.22 - 38.70
52-Week Range	30.55 - 58.80
Beta	-0.07
RSI	44.39
Earnings Date	Jun 3, 2026

About Sandu Pharmaceuticals

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasav...

• Industry: Pharmaceutical Preparations
• Founded: 1899
• Employees: 303
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524703

Financial Performance

In fiscal year 2025, Sandu Pharmaceuticals's revenue was 671.92 million, a decrease of -0.13% compared to the previous year's 672.81 million. Earnings were 15.52 million, an increase of 6.19%.